Abstract
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Original language | English (US) |
---|---|
Pages (from-to) | 536-563 |
Number of pages | 28 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 16 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2018 |
Funding
Alan B. Slifka Foundation; Biomet, Inc.; International Society of Pediatric Oncology; Musculoskeletal Transplant Foundation; and Sarcoma Foundation of America
ASJC Scopus subject areas
- Oncology